Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa

Header

The workshop was organised by the Sub-Regional Representation for Eastern Africa of the World Organisation for Animal Health (WOAH)  as a contribution to activities of the Global Framework for the Progressive Control of Transboundary Animal Diseases (GF-TADs). The workshop was facilitated by International and Regional WOAH Experts, among them Dr. Misheck Mulumba (WOAH Scientific Committee for Animal Diseases, SCAD), Dr. Giancarlo Ferrari (Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana , IZS), Dr. David Paton (The Pirbright Institute, TPI), and Dr. Joseph Hyera (Botswana Vaccine Institute, BVI).

Workshop participants included representatives from Eastern African countries:

  • Ethiopia,
  • Kenya,
  • Rwanda,
  • Somalia,
  • South Sudan,
  • Tanzania and
  • Uganda.

Partner institutions that actively participated in the training included the FAO Regional Office (Eastern Africa), African Union Pan African Veterinary Vaccine Centre (AU- PANVAC), IGAD Centre for Pastoral Areas and Livestock Development (IGAD-ICPALD), International Livestock Research Institute (ILRI), Global Alliance for Livestock Veterinary Medicines (GALVmed).

The opening address was made by the WOAH Representative for Eastern Africa, Dr. Neo Mapitse and Dr. Sabenzia Wekesa who on behalf of the Government of Kenya, officially opened the workshop.

Forme

This workshop marks a strategic moment for Eastern Africa. WOAH is proud to support member countries in advancing through the PCP-FMD stages and enhancing surveillance, diagnostics, and effective vaccination strategies.

Dr. Neo Mapitse, WOAH Representative for Eastern Africa

Forme

Kenya is honored to host this vital workshop aimed at strengthening FMD control across Eastern Africa. We welcome all participants and reaffirm our commitment to regional cooperation in animal health.

Dr Sabenzia Wekesa, Senior Deputy Director of Veterinary Services, Ministry of Agriculture, Kenya

These remarks set the tone for the workshop, emphasising collaboration, regional commitment to FMD control, and the strategic importance of the PCP-FMD framework. The opening presentation was on meeting objectives and adoption of the agenda made by Viola Chemis of WOAH. She reminded about the meeting objectives which were:

  1. Strengthening of FMD control in Eastern Africa,
  2. Knowledge transfer on FMD epidemiology, diagnostics and surveillance with specific focus on circulating FMDV serotypes,
  3. Enhance the capacity of the Epidemiology and Laboratory Focal Points in Member(s) Countries/States,
  4. Enhance networking and information sharing between participating countries and strengthen collaboration between field and laboratory/epidemiology personnel for better FMD prevention, outbreak response and detection,
  5. Facilitate linkages with vaccine producing laboratories and reference laboratories to support FMD diagnosis and vaccine matching
  6. Contribute to the control of FMDV outbreaks becoming endemic to the region while progressively supporting Eastern Africa countries’ standing on the progressive control pathway as outlined by the GF TADs regional roadmap and promoting trade within the context of AfCFTA.

She also took the meeting through the agenda which was adopted as proposed. Ultimately the workshop helped members identify concrete gaps, share possible solutions and build stronger linkages between members, partners and experts for FMD control and promote coordinated action where necessary.

The workshop was organized to provide presentations on the FMD situation, trade opportunities, country-specific control interventions and better understanding of the PCP-FMD stages led by Drs David Paton and Giancarlo Ferrari. This was followed by group work on the GF-TAD focused PCP stages 1 to 3, where countries reflected on their actual status, gaps and opportunities to progress along the PCP-FMD stages.

The group work was organized based on the country’s PCP-FMD stages. The discussions focused on identifying key gaps and proposing practical solutions to advance national FMD control strategies. These were categorised as follows:

PCP-FMD Stage 1 Countries

  • Limited capacity for virus characterization beyond serotyping.
  • Socioeconomic impact studies are either missing or incomplete.
  • Strategic control plans are underdeveloped or not implemented due to budget constraints.
  • Ethiopia demonstrated readiness to progress to Stage 2, contingent on securing adequate funding.

PCP-FMD Stage 2 Countries

  • Surveillance gaps persist, particularly among pastoralist communities.
  • Challenges include uncontrolled livestock movements, inconsistent vaccine supply, and weak biosecurity practices.
  • Proposed solutions included:
    • Adoption of participatory epidemiology approaches.
    • Use of drone technology for vaccine delivery in remote areas (examples from Rwanda).
    • Strengthening livestock traceability systems and public-private partnerships.

Overview of part of the participants. Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

On the second day, experts Dr. Misheck Mulumba and Dr. Joseph Hyera provided presentations and enabled discussions on the WOAH Chapter 8.8 Questionnaire for official control programme endorsement, FMD epidemiology and outbreak response, practices of surveillance and FMD diagnostics.

There was also a presentation on “Insights on How to formulate technical specifications for vaccine procurement, lessons and opportunities from the AgResults Foot and Mouth Disease Vaccine Challenge Project” by GALVmed, “Attributes of effective FMD control and vaccination strategies” by Dr. David Paton and a presentation on FMD vaccine quality control by AU-PANVAC. This was followed by a panel discussion with stakeholders including GALVmed, AU-PANVAC, KEVEVAPI, ILRI, FAO, FAO’s Regional Office for Africa (RAF), NVI-Ethiopia, IGAD-ICPALD, BVI-Botswana, and OVRI-South Africa.

The interactive panel session discussed FMD Diagnosis, Vaccine selection, procurement, quality control and supply. The elaborate discussions of the panel session can be categorized into the following thematic areas:

  1. Virus Exchange: Participants highlighted bureaucratic delays and cold chain management issues as major obstacles to effective virus sample sharing. To address these, the use of Material Transfer Agreements (MTAs) and efforts to build trust between countries and laboratories in the region were recommended.
  2. Laboratory Capacity: Limited participation in proficiency testing and the absence of WOAH-recognized reference laboratories in East Africa were identified as critical gaps. The panel emphasized the need for regional collaboration, increased inter-laboratory comparisons, and sustainable funding mechanisms to build and maintain laboratory capacity.
  3. Coordination and Surveillance: Political and administrative barriers continue to hinder cross-border coordination. Fragmented surveillance systems and limited data sharing were noted. The panel proposed the development of harmonized regional frameworks and the adoption of digital tools to support real-time epidemiological data integration.
  4. Economic Advocacy: Veterinary services often face challenges in articulating the economic impact of FMD to policymakers. The panel recommended conducting integrated analyses that link FMD control to GDP, trade, and livelihoods, and providing technical support to ministries to strengthen advocacy efforts.
  5. Vaccine Access and Quality Control: Unclear processes for vaccine virus selection and limited access to naive animals for testing were discussed. The panel suggested establishing closed farms under veterinary supervision and finalizing regional virus panels to support vaccine evaluation and procurement.
  6. Outbreak Management: Farmers’ reluctance to report suspected cases due to fear of movement restrictions was identified as a barrier to timely outbreak response. The panel advocated for community awareness campaigns and the use of real-time data to facilitate prompt containment measures.

Dr. Sabenzia Wekesa (Kenya). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

The third day of the workshop focused on enhancing regional coordination and understanding the roles of key institutions in FMD control. Presentations were delivered by the Botswana Vaccine Institute (BVI) and Onderstepoort Veterinary Research Institute (OVRI), both WOAH Reference Laboratories, outlining their support for FMD surveillance, diagnostics, and control in Eastern Africa.

Further contributions came from IGAD-ICPALD and the representative of Kenya, who shared experiences on the implementation of cross-border Memoranda of Understanding (MoUs). These presentations addressed harmonized activities, border control measures, animal movement management, and systems for animal identification and traceability.

Participants engaged in a guided group activity to explore challenges and propose solutions for improving coordination and surveillance across borders.

The regional coordination session focused on strengthening collaborative mechanisms for FMD control across Eastern Africa. Discussions highlighted the following key themes:

Annual Review and Regional Information Sharing:

  • Establishment of a designated convener to manage documentation and follow-up actions.
  • Regular national and regional meetings to review progress on vaccination, surveillance, and movement control.
  • Honoring and implementing existing Memoranda of Understanding (MoUs) for transparent data sharing.
  • Proposal for quarterly feedback meetings and structured reporting mechanisms.

Coordination and Harmonization of Measures:

  • Synchronization of mass vaccination campaigns and movement restrictions in border regions.
  • Joint sero-surveillance activities in shared grazing areas and trade corridors.
  • Community awareness and resource mobilization to support joint activities.
  • Bilateral agreements to harmonize trade requirements and facilitate FMD-free trade.

Strengthening Laboratory and Epidemiology Networks:

  • Activation of regional laboratory and epidemiology networks to validate and disseminate FMD intelligence.
  • Establishment of technical working teams along borders (e.g., Kenya-Somalia-Ethiopia) under IGAD coordination.
  • Recommendation to embed the PCP-FMD Support Officer (PSO) within a regional technical body (e.g., ILRI, FAO, RAG) to enhance strategic impact.

Vaccine Quality Control and Harmonization:

  • Regional need for high-quality multivalent FMD vaccines.
  • Development of standard operating procedures (SOPs) for field vaccine monitoring.
  • Capacity building for national regulatory bodies in vaccine registration, cold chain management, and post-vaccination monitoring.

Sharing of Best Practices:

  • Establishment of exchange programmes and joint border activities to build trust and harmonize practices.
  • Proposal for a centralized regional FMD data portal to replace ad hoc information sharing.

Dr David Paton (TPI). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Neo Mapitse (woah). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Giancarlo Ferrari (IZS). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Caesar Lubaba (woah). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Neo Mapitse (woah). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Sabenzia Wekesa (Kenya). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Viola Chemis (woah). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Agol Kwai (WOAH Delegate, South Sudan). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Dr Neo Mapitse (woah). Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Training workshop on FMD epidemiology, diagnostics, and surveillance held in Mombasa, Kenya. Picture (c) Communication (woah) 2025.

Presentations

1. Chemis_Meeting Objectives & Agenda
1. Chemis_Meeting Objectives & Agenda

PDF - 379.03KB

2. Mapitse_FMD Status East-Africa
2. Mapitse_FMD Status East-Africa

PDF - 966.12KB

3. Lubaba_GF-TADs Activities FMD Control
3. Lubaba_GF-TADs Activities FMD Control

PDF - 1.05MB

4. Chemis_Outcomes 5th RMM FMD EA
4. Chemis_Outcomes 5th RMM FMD EA

PDF - 624.62KB

.

5. Lubaba_Trade Opportunities SPS AfCFTA
5. Lubaba_Trade Opportunities SPS AfCFTA

PDF - 430.26KB

6. Golo Jaldessa_FMD Control-Ethiopia
6. Golo Jaldessa_FMD Control-Ethiopia

PDF - 2.84MB

7. Ssenkerra_PCP-FMD Control-Uganda
7. Ssenkerra_PCP-FMD Control-Uganda

PDF - 1.74MB

8. Chemis_Mentimeter session
8. Chemis_Mentimeter session

PDF - 1.03MB

.

9. Ferrari_PCP_FMD GF-TADs stages
9. Ferrari_PCP_FMD GF-TADs stages

PDF - 1.13MB

10. Paton_ PCP stages Group Work
10. Paton_ PCP stages Group Work

PDF - 321.26KB

10b. Aamir_FMD_Stage 1_Group Discussion Presentation
10b. Aamir_FMD_Stage 1_Group Discussion Presentation

PDF - 177.73KB

10c. Morang'a_PCP Stage 2 Groupwork_ discussion
10c. Morang'a_PCP Stage 2 Groupwork_ discussion

PDF - 124.81KB

.

11. Mulumba_FMD Questionnaire WOAH OCP
11. Mulumba_FMD Questionnaire WOAH OCP

PDF - 706.96KB

11b. Mulumba_WOAH EOCP for FMD
11b. Mulumba_WOAH EOCP for FMD

DOCX - 23.97KB

12. Mulumba_FMD Epidemiology in Africa
12. Mulumba_FMD Epidemiology in Africa

PDF - 780.64KB

13. Mulumba_FMD surveillance and outbreak response
13. Mulumba_FMD surveillance and outbreak response

PDF - 645.49KB

.

14. Mulumba_Practical examples on surveillance for new dossiers
14. Mulumba_Practical examples on surveillance for new dossiers

PDF - 631.90KB

15. Hyera_Clinical & Lab Diagnosis of FMD
15. Hyera_Clinical & Lab Diagnosis of FMD

PDF - 1.01MB

16. Maulidi_Formulation of Technical Specs for FMD Vaccine Procurement
16. Maulidi_Formulation of Technical Specs for FMD Vaccine Procurement

PDF - 566.00KB

17. Maulidi_Targeting FMD Vaccines EA - Lessons _AgResults FMD Project
17. Maulidi_Targeting FMD Vaccines EA - Lessons _AgResults FMD Project

PDF - 870.93KB

.

18. Alex Sabuni_KEVEVAPI_FMD-Vaccine Production-East-Africa
18. Alex Sabuni_KEVEVAPI_FMD-Vaccine Production-East-Africa

PDF - 580.70KB

19. Paton_Effective FMD control and vaccination strategies
19. Paton_Effective FMD control and vaccination strategies

PDF - 845.24KB

20. Chitsungo_AU-PANVAC Quality Control of FMD Vaccines
20. Chitsungo_AU-PANVAC Quality Control of FMD Vaccines

PDF - 661.62KB

21. Iradukunda_Recap Day 2 sessions
21. Iradukunda_Recap Day 2 sessions

PDF - 269.28KB

.

22. Hyera_Role of BVI WOAH RL
22. Hyera_Role of BVI WOAH RL

PDF - 498.22KB

23. Mutowembwa_Role of OVRI as WOAH RL for FMD
23. Mutowembwa_Role of OVRI as WOAH RL for FMD

PDF - 867.06KB

24. Wubishet-FMD Activities East-Africa_IGAD-ICPALD
24. Wubishet-FMD Activities East-Africa_IGAD-ICPALD

PDF - 608.10KB

25. Kenya-FMD-Cross border Animal Identifcation
25. Kenya-FMD-Cross border Animal Identifcation

PDF - 1.23MB

26. Iradukunda_Coordination_Group Activity
26. Iradukunda_Coordination_Group Activity

PDF - 424.86KB

More information

Johannesburg, South Africa

GF-TADs Foot-and-mouth Disease (FMD) Risk Assessment Training Workshop

September 21, 2023
Read more
Forme

This training was generously funded by the European Union's SPS-AfCFTA Project IIIIII Cette formation a été généreusement financée par le projet SPS-AfCFTA de l'Union Européenne.

This activity was labeled GF-TADs (Africa)

Share this post